RhumbLine Advisers
EIDX

RhumbLine Advisers’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

RhumbLine Advisers’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$1.79M Sell
2020
Q3 		$782K Sell
2020
Q2 		$847K Buy
2020
Q1 		$863K Buy
2019
Q4 		$998K Buy
2019
Q3 		$599K Sell
2019
Q2 		$520K Sell
2019
Q1 		$445K Buy